Notably, the activity of xanthine oxidase (XO), which is converted from XDH in the inflammatory environment [58] (Figure 2), is increased in LCLs not only from FXS patients, but also from non-FXS-diagnosed patients with FXS family members compared to LCLs from healthy donors [61]. Here, XDH is linked to fragile X syndrome.